Journal Mobile Options
Table of Contents
Vol. 27, No. 5, 2005
Issue release date: 2005
Dev Neurosci 2005;27:321–332

Auditory Deficits Associated with the Frings Mgr1 (Mass1) Mutation in Mice

Klein B.D. · Fu Y.-H. · Ptacek L.J. · White H.S.
Departments of aPharmacology and Toxicology, bNeurobiology and Anatomy, cNeurology and Human Genetics, Howard Hughes Medical Institute, and dAnticonvulsant Drug Development Program, University of Utah, Salt Lake City, Utah, USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


The gene responsible for the audiogenic seizure (AGS) phenotype in Frings mice, which was identified and originally designated Mass1, is now referred to as Mgr1. Although the function of the gene product is not known, the expression pattern suggests a role in the developing CNS. Hearing impairment is often observed in AGS-susceptible rodents and is thought to contribute to the pathology of AGS. We therefore hypothesized that the Frings mouse exhibits early-onset hearing impairment and that the Frings Mgr1 mutation is responsible for the hearing impairment phenotype that leads to the development of AGS susceptibility. Auditory brainstem response (ABR) thresholds were used to evaluate auditory function in mice carrying the Frings Mgr1 allele and were compared with other AGS-susceptible and -resistant mice. ABR testing demonstrated that mice possessing the Frings Mgr1 allele exhibit a mild to moderate level of hearing impairment that is present during the days following hearing onset. Furthermore, the hearing impairment resulting from the Frings Mgr1 allele is relatively stable, which explains the long duration of AGS susceptibility exhibited by Frings mice compared with other AGS-susceptible mice.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Browning RA (1986): Neuroanatomical localization of structures responsible for seizures in the GEPR: Lesion studies. Life Sci 39:857–867.
  2. Ehret G (1983): Psychoacoustics; in Willott JF (ed): The Auditory Psychobiology of the Mouse. Springfield, CC Thomas, pp 470–494.
  3. Ehret G, Romand R (1992): Development of tone response thresholds, latencies and tuning in the mouse inferior colliculus. Brain Res Dev Brain Res 67:317–326.
  4. Faingold CL (1999): Neuronal networks in the genetically epilepsy-prone rat. Adv Neurol 79:311–321.
  5. Faingold CL, Millan MH, Boersma CA, Meldrum BS (1988): Excitant amino acids and audiogenic seizures in the genetically epilepsy-prone rat. 1. Afferent seizure initiation pathway. Exp Neurol 99:678–686.
  6. Faingold CL, Walsh EJ, Maxwell JK, Randall ME (1990): Audiogenic seizure severity and hearing deficits in the genetically epilepsy-prone rat. Exp Neurol 108:55–60.
  7. Foord SM, Jupe S, Holbrook J (2002): Bioinformatics and type II G-protein-coupled receptors. Biochem Soc Trans 30:473–479.
  8. Friauf E, Lohmann C (1999): Development of auditory brainstem circuitry. Activity-dependent and activity-independent processes. Cell Tissue Res 297:187–195.
  9. Frings H, Frings M (1952): Acoustical determinants of audiogenic seizures in laboratory mice. J Acoust Soc Am 24:163–169.

    External Resources

  10. Frings H, Frings M (1953): The production of stocks of albino mice with predictable susceptibilites to audiogenic seizures. Behavior 5:305–319.

    External Resources

  11. Fuller JL (1967): Experiential deprivation and later behavior. Science 158:1645–1652.
  12. Gates GR, Chen CS, Bock GR (1973): Effects of monaural and binaural auditory deprivation on audiogenic seizure susceptibility in BALB-c mice. Exp Neurol 38:488–493.
  13. Henry KR (1967): Audiogenic seizure susceptibility induced in C57BL-6J mice by prior auditory exposure. Science 158:938–940.
  14. Henry KR (1985): Cochlear function and audiogenic seizures: Developmental covariance in the LP/J mouse. Dev Psychobiol 18:461–466.
  15. Henry KR, Buzzone R (1986): Auditory physiology and behavior in RB/1bg, RB/3bg, and their F1 hybrid mice (Mus musculus): Influence of genetics, age, and acoustic variables on audiogenic seizure thresholds and cochlear functions. J Comp Psychol 100:46–51.
  16. Henry KR, Haythorn MM (1975): Auditory similarities associated with genetic and experimental acoustic deprivation. J Comp Physiol Psychol 89:213–218.
  17. Johnson KR, Zheng QY, Erway LC (2000): A major gene affecting age-related hearing loss is common to at least ten inbred strains of mice. Genomics 70:171–180.
  18. Johnson KR, Zheng QY, Weston MD, Ptacek LJ, Noben-Trauth K (2005):The Mass1frings mutation underlies early onset hearing impairment in BUB/BnJ mice, a model for the auditory pathology of Usher syndrome IIC. Genomics 85:582–590.
  19. Kai N, Niki H (2002): Altered tone-induced Fos expression in the mouse inferior colliculus after early exposure to intense noise. Neurosci Res 44:305–313.
  20. Kesner RP (1966): Subcortical mechanisms of audiogenic seizures. Exp Neurol 15:192–205.
  21. Klein BD, Fu YH, Ptacek LJ, White HS (2004): c-Fos immunohistochemical mapping of the audiogenic seizure network and tonotopic neuronal hyperexcitability in the inferior colliculus of the Frings mouse. Epilepsy Res 62:13–25.
  22. Klein BD, Ptacek LJ, Wilcox KS, White HS (2002): The Frings monogenic audiogenic seizure-susceptible (Mass1) gene mutation is associated with a lower threshold for brainstem seizures. Epilepsia 43:3.067.
  23. Kwon J, Pierson M (1997): Fos-immunoreactive responses in inferior colliculi of rats with experimental audiogenic seizure susceptibility. Epilepsy Res 27:89–99.
  24. McGinn MD, Willott JF, Henry KR (1973): Effects of conductive hearing loss on auditory evoked potentials and audiogenic seizures in mice. Nat New Biol 244:255–256.
  25. McMillan DR, Kayes-Wandover KM, Richardson JA, White PC (2002): Very large G protein-coupled receptor-1, the largest known cell surface protein, is highly expressed in the developing central nervous system. J Biol Chem 277:785–792.
  26. McMillan DR, White PC (2004): Loss of the transmembrane and cytoplasmic domains of the very large G-protein-coupled receptor-1 (VLGR1 or Mass1) causes audiogenic seizures in mice. Mol Cell Neurosci 26:322–329.
  27. Millan MH, Meldrum BS, Boersma CA, Faingold CL (1988): Excitant amino acids and audiogenic seizures in the genetically epilepsy-prone rat. 2. Efferent seizure propagating pathway. Exp Neurol 99:687–698.
  28. Nakayama J, Fu YH, Clark AM, et al (2002): A nonsense mutation of the MASS1 gene in a family with febrile and afebrile seizures. Ann Neurol 52:654–657.
  29. Neumann PE, Collins RL (1991): Genetic dissection of susceptibility to audiogenic seizures in inbred mice. Proc Natl Acad Sci USA 88:5408–5412.
  30. Noben-Trauth K, Zheng QY, Johnson KR (2003): Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss. Nat Genet 35:21–23.
  31. Norris CH, Cawthon TH, Carroll RC (1977): Kanamycin priming for audiogenic seizures in mice. Neuropharmacology 16:375–380.
  32. Parham K, Sun X-M, Kilgard M (2001): Noninvasive assessment of auditory function in mice: Auditory brainstem response and distortion product otoacoustic emissions; in Willott JF (ed): Handbook of Mouse Auditory Research: From Behavior to Molecular Biology. Boca Raton, CRC Press, pp 37–58.
  33. Parks TN (1999): Cochlear influences on development of the brainstem auditory system; in Johnson F (ed): The Biology of Early Influences. New York, Kluwer Academic/Plenum, pp 15–34.
  34. Pierson M, Snyder-Keller A (1994): Development of frequency-selective domains in inferior colliculus of normal and neonatally noise-exposed rats. Brain Res 636:55–67.
  35. Ptacek LJ, Fu YH (2003): What’s new in epilepsy genetics? Mol Psychiatry 8:463–465.
  36. Reigle CE (1998): Audiogenic seizures in mice and rats; in Albertson TE (ed): Neuropharmacology Methods in Epilepsy Research. Boca Raton, CRC Press, pp 127–154.
  37. Romand R, Ehret G (1990): Development of tonotopy in the inferior colliculus. 1. Electrophysiological mapping in house mice. Brain Res Dev Brain Res 54:221–234.
  38. Ross KC, Coleman JR (2000): Developmental and genetic audiogenic seizure models: Behavior and biological substrates. Neurosci Biobehav Rev 24:639–653.
  39. Sanes DH, Constantine-Paton M (1983): Altered activity patterns during development reduce neural tuning. Science 221:1183–1185.
  40. Schlesinger K, Boggan W, Freedman DX (1965): Genetics of audiogenic seizures. 1. Relation to brain serotonin and norepinephrine in mice. Life Sci 4:2345–2351.
  41. Skradski SL, Clark AM, Jiang H, White HS, Fu YH, Ptacek LJ (2001): A novel gene causing a mendelian audiogenic mouse epilepsy. Neuron 31:537–544.
  42. Skradski SL, White HS, Ptacek LJ (1998): Genetic mapping of a locus (mass1) causing audiogenic seizures in mice. Genomics 49:188–192.
  43. Steel K, Niaussat MM, Bock GR (1983): The genetics of hearing; in Willott JF (ed): The Auditory Psychobiology of the Mouse. Springfield, CC Thomas, pp 341–394.
  44. Weston MD, Luijendijk MW, Humphrey KD, Moller C, Kimberling WJ (2004): Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II. Am J Hum Genet 74:357–366.
  45. White HS, Patel S, Meldrum BS (1992): Anticonvulsant profile of MDL 27,266: An orally active, broad-spectrum anticonvulsant agent. Epilepsy Res 12:217–226.
  46. Willott JF, Lu SM (1980): Midbrain pathways of audiogenic seizures in DBA/2 mice. Exp Neurol 70:288–299.
  47. Zheng QY, Johnson KR, Erway LC (1999): Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 130:94–107.

Pay-per-View Options
Direct payment This item at the regular price: USD 9.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 8.00